{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:41:14Z","timestamp":1785415274182,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","award":["Aide  \u00e0 la mobilit\u00e9"],"award-info":[{"award-number":["Aide  \u00e0 la mobilit\u00e9"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dobutamine exerts its pharmacological effects by stimulating \u03b11-, \u03b21-, and \u03b22-adrenergic receptors. Activation of these receptors increase both the force of cardiac contraction (inotropy) and heart rate (chronotropy). Despite its well-established cardiac effects, the influence of dobutamine on vascular tone remains poorly understood and its impact on venous return and the underlying determinants of this process has not been thoroughly investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In eight healthy pigs, we measured cardiac output (CO) by pulmonary thermodilution, right atrial pressure (RAP) and arterial pressure. We measured mean circulatory filling pressure (PMSF), by transiently inflating a balloon in the right atrium and thus temporarily stopping blood flow and allowing venous pressure to plateau. After obtaining baseline measurements, dobutamine was administered at 10 and 20 \u00b5g\/kg\/min. Two fluids bolus were given at baseline and with a dobutamine infusion at 20 \u00b5g\/kg\/min to produce cardiac function curves. Repeated measures ANOVA were performed for comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Dobutamine increased CO from 3.4\u2009\u00b1\u20090.3 to 4.3\u2009\u00b1\u20090.4 (p\u2009=\u20090.0145) and 4.5\u2009\u00b1\u20090.5 L\/min\/m\n                      <jats:sup>2<\/jats:sup>\n                      (p\u2009=\u20090.0163) at 10 and 20\u00a0\u00b5g\/kg\/min, with an upward shift of the cardiac function curve, indicating improved inotropy. Stroke volume and RAP did not change, but heart rate increases linearly with the dosage of dobutamine (p\u2009=\u20090.0009). Mean arterial pressure did not change but systemic vascular resistance decreased (p\u2009&lt;\u20090,0001). PMSF also increased with dobutamine from 8.7\u2009\u00b1\u20090.7 to 9.8\u2009\u00b1\u20090.8 and 10.4\u2009\u00b1\u20090.8\u00a0mmHg at 20\u00a0\u00b5g\/kg\/min (p\u2009=\u20090.0455), and the pressure difference for venous return (PMSF-RAP) increased from 5.6\u2009\u00b1\u20090.6 to 7.3\u2009\u00b1\u20090.6 at 10\u00a0\u00b5g\/kg\/min and 7.0\u2009\u00b1\u20090.5\u00a0mmHg at 20\u00a0\u00b5g\/kg\/min (p\u2009=\u20090.0292). There was no change in venous compliance or resistance to venous return, thus indicating a reduction in venous capacitance. No time-effect of dobutamine was detected over a 2-h period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dobutamine increased cardiac output by increasing cardiac function by increase heart rate but also by improving venous return by increasing PMSF by decreasing venous capacitance and lowering arterial vascular resistance, underscoring the importance of its \u03b11 and \u03b22-adrenergic activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00929-x","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:44:58Z","timestamp":1782877498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hidden effects of dobutamine on cardiac output"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-3364","authenticated-orcid":false,"given":"Christopher","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Shaikhain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8576-0257","authenticated-orcid":false,"given":"Sheldon","family":"Magder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"11","key":"929_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","volume":"50","author":"C Jung","year":"2024","unstructured":"Jung C, Bruno RR, Jumean M et al (2024) Management of cardiogenic shock: state-of-the-art. Intensive Care Med 50(11):1814\u20131829. https:\/\/doi.org\/10.1007\/s00134-024-07618-x","journal-title":"Intensive Care Med"},{"issue":"10466","key":"929_CR2","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/S0140-6736(24)01818-X","volume":"404","author":"E L\u00fcsebrink","year":"2024","unstructured":"L\u00fcsebrink E, Binzenh\u00f6fer L, Adamo M et al (2024) Cardiogenic shock. Lancet 404(10466):2006\u20132020. https:\/\/doi.org\/10.1016\/S0140-6736(24)01818-X","journal-title":"Lancet"},{"issue":"4","key":"929_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00000441-198710000-00005","volume":"294","author":"RR Ruffolo","year":"1987","unstructured":"Ruffolo RR (1987) Review: the pharmacology of Dobutamine. Am J Med Sci 294(4):244\u2013248. https:\/\/doi.org\/10.1097\/00000441-198710000-00005","journal-title":"Am J Med Sci"},{"issue":"2","key":"929_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7326\/0003-4819-100-2-313","volume":"100","author":"RR Ruffolo","year":"1984","unstructured":"Ruffolo RR (1984) The mechanism of action of Dobutamine. Ann Intern Med 100(2):311\u2013311. https:\/\/doi.org\/10.7326\/0003-4819-100-2-313","journal-title":"Ann Intern Med"},{"issue":"5","key":"929_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/cc11395","volume":"16","author":"S Magder","year":"2012","unstructured":"Magder S (2012) Bench-to-bedside review: an approach to hemodynamic monitoring - Guyton at the bedside. Crit Care 16(5):236. https:\/\/doi.org\/10.1186\/cc11395","journal-title":"Crit Care"},{"issue":"4","key":"929_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0883-9441(96)90026-X","volume":"11","author":"S Magder","year":"1996","unstructured":"Magder S, Vanelli G (1996) Circuit factors in the high cardiac output of sepsis. J Crit Care 11(4):155\u2013166. https:\/\/doi.org\/10.1016\/S0883-9441(96)90026-X","journal-title":"J Crit Care"},{"issue":"6","key":"929_CR7","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1164\/ajrccm.160.6.9808019","volume":"160","author":"P Datta","year":"1999","unstructured":"Datta P, Magder S (1999) Hemodynamic response to Norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia. Am J Respir Crit Care Med 160(6):1987\u20131993. https:\/\/doi.org\/10.1164\/ajrccm.160.6.9808019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"929_CR8","doi-asserted-by":"publisher","first-page":"H94","DOI":"10.1152\/ajpheart.1978.234.1.H94","volume":"234","author":"RE Samar","year":"1978","unstructured":"Samar RE, Coleman TG (1978) Measurement of mean circulatory filling pressure and vascular capacitance in the rat. Am J Physiol Heart Circ Physiol 234(1):H94\u2013H100. https:\/\/doi.org\/10.1152\/ajpheart.1978.234.1.H94","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"17","key":"929_CR9","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"929_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1152\/physrev.1955.35.1.123","volume":"35","author":"AC Guyton","year":"1955","unstructured":"Guyton AC (1955) Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol Rev 35(1):123\u2013129. https:\/\/doi.org\/10.1152\/physrev.1955.35.1.123","journal-title":"Physiol Rev"},{"issue":"3","key":"929_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1152\/ajplegacy.1957.189.3.609","volume":"189","author":"AC Guyton","year":"1957","unstructured":"Guyton AC, Lindsey AW, Abernathy B, Richardson T (1957) Venous return at various right atrial pressures and the normal venous return curve. Am J Physiol - Legacy Content 189(3):609\u2013615. https:\/\/doi.org\/10.1152\/ajplegacy.1957.189.3.609","journal-title":"Am J Physiol - Legacy Content"},{"issue":"1","key":"929_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04024-x","volume":"26","author":"R Persichini","year":"2022","unstructured":"Persichini R, Lai C, Teboul JL, Adda I, Gu\u00e9rin L, Monnet X (2022) Venous return and mean systemic filling pressure: physiology and clinical applications. Crit Care 26(1):150. https:\/\/doi.org\/10.1186\/s13054-022-04024-x","journal-title":"Crit Care"},{"issue":"1","key":"929_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1438-7","volume":"20","author":"S Magder","year":"2016","unstructured":"Magder S (2016) Volume and its relationship to cardiac output and venous return. Crit Care 20(1):271. https:\/\/doi.org\/10.1186\/s13054-016-1438-7","journal-title":"Crit Care"},{"issue":"3","key":"929_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1748-1716.1990.tb08853.x","volume":"138","author":"L Bell","year":"1990","unstructured":"Bell L, Hennecken J, Zaret BL, Rutlen DL (1990) Alpha\u2010adrenergic regulation of splanchnic volume and cardiac output in the dog. Acta Physiol Scand 138(3):321\u2013329. https:\/\/doi.org\/10.1111\/j.1748-1716.1990.tb08853.x","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"929_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.RES.46.1.133","volume":"46","author":"RM Fuchs","year":"1980","unstructured":"Fuchs RM, Rutlen DL, Powell WJ (1980) Effect of dobutamine on systemic capacity in the dog. Circ Res 46(1):133\u2013138. https:\/\/doi.org\/10.1161\/01.RES.46.1.133","journal-title":"Circ Res"},{"issue":"5","key":"929_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.trsl.2010.07.011","volume":"156","author":"OJ How","year":"2010","unstructured":"How OJ, R\u00f8sner A, Kildal AB et al (2010) Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock. Transl Res 156(5):273\u2013281. https:\/\/doi.org\/10.1016\/j.trsl.2010.07.011","journal-title":"Transl Res"},{"issue":"5","key":"929_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10877-010-9258-9","volume":"24","author":"BF Geerts","year":"2010","unstructured":"Geerts BF, Maas JJ, Aarts LP, Pinsky MR, Jansen JR (2010) Partitioning the resistances along the vascular tree: effects of dobutamine and hypovolemia in piglets with an intact circulation. J Clin Monit Comput 24(5):377\u2013384. https:\/\/doi.org\/10.1007\/s10877-010-9258-9","journal-title":"J Clin Monit Comput"},{"issue":"3","key":"929_CR18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/01.CIR.84.3.1210","volume":"84","author":"PF Binkley","year":"1991","unstructured":"Binkley PF, Murray KD, Watson KM, Myerowitz PD, Leier CV (1991) Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function. Circulation 84(3):1210\u20131215. https:\/\/doi.org\/10.1161\/01.CIR.84.3.1210","journal-title":"Circulation"},{"issue":"23","key":"929_CR19","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","volume":"100","author":"XL Rudner","year":"1999","unstructured":"Rudner XL, Berkowitz DE, Booth JV et al (1999) Subtype specific regulation of human vascular \u03b11 -adrenergic receptors by vessel bed and age. Circulation 100(23):2336\u20132343. https:\/\/doi.org\/10.1161\/01.CIR.100.23.2336","journal-title":"Circulation"},{"issue":"2","key":"929_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2165\/00044011-200828020-00006","volume":"28","author":"J Ahonen","year":"2008","unstructured":"Ahonen J, Aranko K, Iivanainen A, Maunuksela EL, Paloheimo M, Olkkola KT (2008) Pharmacokinetic-pharmacodynamic relationship of dobutamine and heart rate, stroke volume and cardiac output in healthy volunteers. Clin Drug Investig 28(2):121\u2013127. https:\/\/doi.org\/10.2165\/00044011-200828020-00006","journal-title":"Clin Drug Investig"},{"issue":"5","key":"929_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/01.RES.34.5.663","volume":"34","author":"NW Robie","year":"1974","unstructured":"Robie NW, Nutter DO, Moody C, Mcnay JL (1974) In vivo analysis of adrenergic receptor activity of dobutamine. Circ Res 34(5):663\u2013671. https:\/\/doi.org\/10.1161\/01.RES.34.5.663","journal-title":"Circ Res"},{"issue":"4","key":"929_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1476-5381.1980.tb07917.x","volume":"69","author":"D McCaig","year":"1980","unstructured":"McCaig D, Parratt JR (1980) A comparison of the cardiovascular effects of dobutamine and a new dopamine derivative (D4975) during shock induced by E. coli endotoxin. Br J Pharmacol 69(4):651\u2013656. https:\/\/doi.org\/10.1111\/j.1476-5381.1980.tb07917.x","journal-title":"Br J Pharmacol"},{"issue":"1","key":"929_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2019.07.001","volume":"33","author":"PA Pellikka","year":"2020","unstructured":"Pellikka PA, Arruda-Olson A, Chaudhry FA et al (2020) Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography. J Am Soc Echocardiogr 33(1):1-41.e8. https:\/\/doi.org\/10.1016\/j.echo.2019.07.001","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"929_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050751","volume":"60","author":"A Dubin","year":"2024","unstructured":"Dubin A, Mugno M (2024) The effects of dobutamine in septic shock: an updated narrative review of clinical and experimental studies. Medicina 60(5):751. https:\/\/doi.org\/10.3390\/medicina60050751","journal-title":"Medicina"},{"issue":"2","key":"929_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.CCM.0000048621.36569.69","volume":"31","author":"M Bucher","year":"2003","unstructured":"Bucher M, Kees F, Taeger K, Kurtz A (2003) Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 31(2):566\u2013571. https:\/\/doi.org\/10.1097\/01.CCM.0000048621.36569.69","journal-title":"Crit Care Med"},{"issue":"2","key":"929_CR26","doi-asserted-by":"publisher","first-page":"H152","DOI":"10.1152\/ajpheart.1977.232.2.H152","volume":"232","author":"JF Green","year":"1977","unstructured":"Green JF (1977) Mechanism of action of isoproterenol on venous return. Am J Physiol 232(2):H152-156. https:\/\/doi.org\/10.1152\/ajpheart.1977.232.2.H152","journal-title":"Am J Physiol"},{"issue":"1","key":"929_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40635-025-00804-1","volume":"13","author":"L Calabr\u00f3","year":"2025","unstructured":"Calabr\u00f3 L, Annoni F, Taccone FS (2025) Dobutamine administration: a proposal for a standardized approach. Intensive Care Med Exp 13(1):89. https:\/\/doi.org\/10.1186\/s40635-025-00804-1","journal-title":"Intensive Care Med Exp"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00929-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:44:59Z","timestamp":1782877499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00929-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00929-x","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}